ARTICLE | Clinical News
Cangene regulatory update
June 20, 1994 7:00 AM UTC
CNJ (Toronto) received European Patent No. 329,882 covering its Nucleic Acid Sequence-Based Amplification (NASBA) technology, which enables the detection of disease and microbial contamination at the ...